UBS AM
ATEX icon

UBS AM’s Anterix ATEX Stock Holding History

UBS AM’s Portfolio ATEX Stock Details ATEX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.34K Hold
13
– – ﹤0.01% 3589
2026
Q1 		$496 Hold
13
– – ﹤0.01% 3724
2025
Q4 		$284 Buy
+13
New +$270 ﹤0.01% 3262
2025
Q3 		– Sell
-36,349
Closed -$932K – 2301
2025
Q2 		$932K Buy
36,349
+12,578
+53% +$368K ﹤0.01% 2398
2025
Q1 		$870K Sell
23,771
-300
-1% -$10.3K ﹤0.01% 2367
2024
Q4 		$738K Buy
24,071
+1,529
+7% +$50.8K ﹤0.01% 2461
2024
Q3 		$849K Sell
22,542
-1,931
-8% -$74.4K ﹤0.01% 2467
2024
Q2 		$969K Buy
24,473
+10,781
+79% +$349K ﹤0.01% 2382
2024
Q1 		$460K Hold
13,692
– – ﹤0.01% 2312
2023
Q4 		$456K Hold
13,692
– – ﹤0.01% 2348
2023
Q3 		$430K Hold
13,692
– – ﹤0.01% 2350
2023
Q2 		$452K Hold
13,692
– – ﹤0.01% 2364
2023
Q1 		$452K Buy
13,692
+1,749
+15% +$57.3K ﹤0.01% 2364
2022
Q4 		$384K Hold
11,943
– – ﹤0.01% 2276
2022
Q3 		$427K Buy
11,943
+1,754
+17% +$72.8K ﹤0.01% 2396
2022
Q2 		$418K Buy
10,189
+2,074
+26% +$101K ﹤0.01% 2365
2022
Q1 		$470K Hold
8,115
– – ﹤0.01% 2483
2021
Q4 		$477K Sell
8,115
-540
-6% -$32.8K ﹤0.01% 2577
2021
Q3 		$525K Buy
8,655
+4,578
+112% +$268K ﹤0.01% 2481
2021
Q2 		$245K Buy
+4,077
New +$204K ﹤0.01% 2685
2016
Q3 		– Sell
-55,096
Closed -$1.18M – 2596
2016
Q2 		$1.18M Sell
55,096
-149,258
-73% -$4.7M ﹤0.01% 1573
2016
Q1 		$7.02M Buy
204,354
+176,608
+637% +$4.67M 0.01% 940
2015
Q4 		$763K Sell
27,746
-4,734
-15% -$129K ﹤0.01% 1846
2015
Q3 		$971K Buy
32,480
+57
+0.2% +$1.87K ﹤0.01% 1735
2015
Q2 		$1.37M Buy
32,423
+1,123
+4% +$53K ﹤0.01% 1566
2015
Q1 		$1.56M Buy
+31,300
New +$1.52M ﹤0.01% 1468

Other funds holding ATEX

OCAM
Owl Creek Asset Management New York $1.21B AUM 169.99% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
HCL
Heard Capital LLC Chicago, Illinois $2.34B AUM 46.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PM
Plustick Management Charlottesville, Virginia $269M AUM 340.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $11.1B AUM 41.79% 1-Year Est. Return

UBS AM's ATEX Position: Q2 2026 in Review

UBS AM held its Anterix (ATEX) position steady in Q2 2026 at 13 shares worth $1.34K. The position accounts for ﹤0.01% of the portfolio, ranked #3589.

UBS AM first reported a position in ATEX in Q1 2015 and has held it in 26 quarters since. The position peaked at $7.02M in Q1 2016. 172 funds tracked by Wall St. Rank hold ATEX as of Q2 2026.

  • UBS AM held 13 shares of Anterix worth $1.34K as of Q2 2026.
  • UBS AM left its Anterix share count unchanged in Q2 2026.
  • Anterix made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #3589 holding.
  • UBS AM first reported a position in Anterix in Q1 2015 and has held it in 26 quarters since.
  • UBS AM's Anterix position peaked at $7.02M in Q1 2016.
  • 172 funds tracked by Wall St. Rank held Anterix as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.